You searched for: "" but we corrected it to "*"

Did you mean to search for ""? Click here to show those results.

The results has been filter on Tags containing Healthcare / Pharmaceutical / Wellness.
ANA has found 386 results for you, in 708 ms.
Didn’t find what you were looking for? Try the Advanced Search!

Research papers

Competitor analysis in defence of a brand leader

In the U.K. retail antibacterial market, Amoxil is brand leader. However, share varies considerably in market sub-segments as does the source of competition. The Market Research Department is a prime contributor to competitor analysis, all the more...

Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: Roger Western
February 27, 1985
×

Citation

Western, R. (1985a, February 27). Competitor analysis in defence of a brand leader. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/competitor-analysis-in-defence-of-a-brand-leader


Research papers

Competitor analysis by patient monitoring

The development of market research and marketing shows us that, based on a series of market research results, the patient is playing an ever larger role in the marketing strategies of the pharmaceutical industry. We can see that the patient receives...

Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Authors: Ingrid Köpl, Gerd Bögel
Company: Marplan Forschungsgesellschaft mbH
February 27, 1985
×

Citation

Köpl and Bögel (1985a, February 27). Competitor analysis by patient monitoring. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/competitor-analysis-by-patient-monitoring


Research papers

The use of competitive analysis in R&D planning

The need for strong "market research" or competitive analysis is no longer limited to strategic or market planning functions within a company. Research and development, one of the most essential determinants of long-term success in the pharmaceutical...

Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: Tamara J. Erickson
February 27, 1985
×

Citation

Erickson, T. J. (1985a, February 27). The use of competitive analysis in R&D planning. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/the-use-of-competitive-analysis-in-r-d-planning


Case studies

In-depth pharmaceutical competitor analysis

The paper presents an example of a case study of in-depth competitor analysis in the Japanese pharmaceutical industry. Prior to outlining the case study, and to place it in perspective, a brief overview is provided of key points of difference between...

Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: William Hall
February 27, 1985
×

Citation

Hall, W. (1985a, February 27). In-depth pharmaceutical competitor analysis. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/in-depth-pharmaceutical-competitor-analysis


Research papers

Pharmaceutical industry competitor analysis

The key to change in the pharmaceutical industry is technology and new drug introductions versus exposure to generic competition. The net effect equals the critical stock selection criterion for pharmaceutical investing.

Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: Christina Heuer
February 27, 1985
×

Citation

Heuer, C. (1985a, February 27). Pharmaceutical industry competitor analysis . ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/pharmaceutical-industry-competitor-analysis-


Research papers

MediLink

During the Spring and Summer of 1983 Medilink set up a pilot medical market research operation, involving ten London practices, followed by a larger test market of 50 practices. In April 1984 Medilink expanded the panel to be a national panel of 150...

Catalogue: Seminar 1984: Are Interviewers Obsolete?
Author: Peter Barton
June 15, 1984
×

Citation

Barton, P. (1984a, June 15). MediLink. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/medilink


Research papers

Micro networks

The developments in micro networks have already begun to have an effect on the communication of information between the pharmaceutical industry and the medical profession. However the links between the different groups of the medical profession e.g....

Catalogue: Seminar 1984: Market Research And M.M.I.S.
Authors: Hilary Thomas, Alan J. Bowditch
January 25, 1984
×

Citation

Thomas and Bowditch (1984a, January 25). Micro networks. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/micro-networks


Research papers

Making the editorial matter of medical magazines more attractive

In Germany two continuous research services are available measurement the relative readership of the editorial elements in 30 major medical magazines. One service is private, the other one is part of the syndicated audience research organisation...

Catalogue: Seminar 1983: Publishing A Better Product
Authors: Ilse Meier, Gerhard Zacharias
November 23, 1983
×

Citation

Meier and Zacharias (1983a, November 23). Making the editorial matter of medical magazines more attractive. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/making-the-editorial-matter-of-medical-magazines-more-attractive


Research papers

The impact of new technologies on the pharmaceutical marketing researcher

The role of IMS in the pharmaceutical industry is as a data provider. As such I will discuss new technologies as they may impact the provision of data to the industry and to alert you to technologies that are likely to become important in the...

Catalogue: Seminar 1983: Information For Decision Making In The Pharmaceutical Industry
Author: Dennis A. Calvanese
June 15, 1983
×

Citation

Calvanese, D. A. (1983a, June 15). The impact of new technologies on the pharmaceutical marketing researcher. ANA - ESOMAR. Retrieved May 10, 2024, from


https://ana.esomar.org/documents/the-impact-of-new-technologies-on-the-pharmaceutical-marketing-researcher